SMURF1 and familial pancreatic carcinoma: In conclusion, our results show that inhibition of SMURF1 can inhibit the proliferation and migration of pancreatic cancer cells, and Smurf1-IN-A01 is a promising candidate drug for the treatment of pancreatic cancer.